Allergy Treatment Market Size Qualitative Insights on Application and Outlook by Share, Future Growth 2026

The allergy treatment market was valued at $24.65 billion in 2017 and is expected to reach $40.36 billion by 2025.

PORTLAND, OREGON, USA, Sept. 29, 2022 / โ€” The Allergy Treatment Market report provides in-depth analysis of market dynamics including drivers and restraints, key winning strategies, market size and projections, competitive landscape and major segments. Increased prevalence of allergens and high tobacco consumption that can induce several allergies is driving the growth of the global allergy treatment market. However, patent expirations, generic drug competition, and availability of alternative and complementary therapies are hampering the market growth. On the contrary, increased patient awareness of food allergies is expected to create lucrative opportunities for market players over the coming years.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

Global Allergy Treatment Market report includes various market leading companies such as GlaxoSmithKline, Allergopharma, Allergan, Inc., Schering-Plough Corporation, Collegium Pharmaceutical, Inc., Allergy therapy, Allergon, Genentech Inc., McNeil Consumer Healthcare and Meda. Pharmaceuticals, Inc. Market players have adopted several strategies including partnerships, collaboration, mergers and acquisitions, and new product launches to maintain their market leadership.

The food allergy segment is expected to grow at the fastest CAGR of 8.3% during the forecast period, owing to the increased patient awareness of food allergies. However, the increased prevalence of allergic rhinitis across the globe helped the rhinitis segment to acquire the largest market share in 2017 accounting for around 40% of the total market share. Other segments analyzed in the report include asthma, skin allergy, food allergy and others.

In 2017, the anti-allergy segment garnered around 89% market share, owing to the growing inclination towards over-the-counter (OTC) drugs for the treatment of allergic diseases. Furthermore, the segment is expected to continue its dominance in the market. However, the immunotherapy treatment segment is expected to register the fastest CAGR of 8.5% during the forecast period, owing to the growing awareness among healthcare professionals on the use of immunotherapy for the treatment allergies.

The global allergy treatment market report includes several major distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies. In 2017, the retail pharmacy segment garnered about half of the total market share and is expected to maintain its dominance throughout the market period. However, the online pharmacy segment would show the fastest CAGR of 7.9% from 2018 to 2025, owing to increased internet penetration and increased sales of drugs to treat allergic reactions through of online retailers. Moreover, the hospital pharmacy segment would witness a gradual growth in the region.

North America contributed about one-third of the total market revenue in 2017. It is estimated to dominate the market throughout the forecast period, due to well-established healthcare infrastructure and increasing the adoption of immunotherapy solutions to treat allergic diseases. However, the Asia-Pacific region would exhibit the fastest CAGR of 7.5% until 2025, due to the increasing prevalence of various allergic diseases such as asthma and rhinitis in the region. Other regions analyzed in the report are Europe and Latin America, Middle East and Africa (LAMEA).

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ

Contraceptives market

Mechanical Ventilators Market

๐€๐•๐„๐๐”๐„- ๐€ ๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐‹๐ข๐›๐ซ๐š๐ซ๐ฒ ๐‹๐ข๐›๐ซ๐š๐ซ๐ฒ (๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐จ๐ง-๐๐ž๐ฆ๐š๐ง๐, ๐ฌ๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐›๐š๐ฌ๐ž๐ ๐ฉ๐ซ๐ข๐œ๐ข๐ง๐  ๐ฆ๐จ๐๐ž๐ฅ) ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ž๐ ๐›๐ฒ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

AMR introduces its subscription-based premium online library Avenue, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

๐†๐ž๐ญ ๐š๐ง ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ž ๐จ๐Ÿ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐š๐ง๐ฒ ๐ญ๐ข๐ฆ๐ž ๐Ÿ๐ซ๐จ๐ฆ ๐š๐ง๐ฒ ๐๐ž๐ฏ๐ข๐œ๐ž ๐š๐ง๐ ๐š๐ง๐ฒ๐ฐ๐ก๐ž๐ซ๐ž. Access:

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฅ๐ฅ๐ข๐ž๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ :

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of โ€œmarket research reportsโ€ and โ€œBusiness Intelligence solutionsโ€. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services across 11 verticals, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior executives from leading companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

David Correa
Allied Analytics LLP
write to us here
Visit us on social media:

Comments are closed.